(19)
(11) EP 1 819 700 A2

(12)

(88) Date of publication A3:
21.09.2006

(43) Date of publication:
22.08.2007 Bulletin 2007/34

(21) Application number: 05852840.7

(22) Date of filing: 02.12.2005
(51) International Patent Classification (IPC): 
C07D 413/12(2006.01)
A61P 31/18(2006.01)
A61K 31/513(2006.01)
(86) International application number:
PCT/US2005/043728
(87) International publication number:
WO 2006/060712 (08.06.2006 Gazette 2006/23)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 03.12.2004 US 633132 P

(71) Applicants:
  • Merck & Co., Inc.
    Rahway, NJ 07065-0907 (US)
  • ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.
    00040 Pomezia (IT)

(72) Inventors:
  • BELYK, Kevin, M.
    Rahway, New Jersey 07065-0907 (US)
  • MORRISON, Henry, G.
    Rahway, New Jersey 07065-0907 (US)
  • JONES, Philip
    I-00040 Pomezia (IT)
  • SUMMA, Vincenzo
    I-00040 Pomezia (IT)

(74) Representative: Man, Jocelyn et al
Merck & Co., Inc. European Patent Department
Hertford Road Hoddesdon Hertfordshire EN11 9BU
Hertford Road Hoddesdon Hertfordshire EN11 9BU (GB)

   


(54) POTASSIUM SALT OF AN HIV INTERGRASE INHIBITOR